Skip to main content

Merit Medical Launches the PreludeSYNC EZ™ Radial Compression Device

Written by Customer Service on . Posted in Public Companies.

Unique band provides precise placement and clear visibility of the access site, optimizing hemostasis for radial artery procedures

SOUTH JORDAN, Utah, Nov. 21, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the PreludeSYNC EZ™ Radial Compression Device.

The new device is the latest in Merit’s ongoing excellence and leadership in advancing transradial access for endovascular patient care. It complements a robust radial portfolio of products that includes the Prelude IDeal™, Merit’s thin-walled hydrophilic sheath introducer with superior kink and compression resistance.1

Designed for optimal clinical performance, the PreludeSYNC EZ assists in achieving access site patent hemostasis (the prevention of bleeding) following radial artery access procedures.

A unique cinch-style wrist band supports controlled and precise two-handed placement, a key feature that differentiates it from other radial compression devices on the market. A large window provides clear visibility designed to further help with precise placement. Created with the patient and clinician in mind,​ the PreludeSYNC EZ provides a simplified alternative to the two-strap compression band currently on the market.

Radial artery access is a minimally invasive approach to diagnosing and treating a wide range of conditions. Through a pinhole-size site in the wrist, a catheter is inserted into the radial artery. Under imaging guidance, the catheter is then threaded through the body’s network of blood vessels to the location needing treatment.

The rate of radial artery access use in the United States is on the rise. Between 2011 and 2018, radial access for diagnostic angiograms (X-ray procedures that show blocked or narrowed vessels in the heart) increased from 17.5% to 60.4%.2 Radial access rates for percutaneous coronary intervention (procedures used to open blocked vessels) also grew from 14.0% to 51.8%.2 Radial coronary angiography and PCI have been linked to better clinical outcomes. 3 Benefits include fewer bleeding complications, improved patient comfort, and decreased procedure costs compared to femoral procedures, or those performed through the femoral artery in the groin.3

Learn more about the PreludeSYNC EZ Radial Compression Device.

“Merit Medical is fully invested in being a leader in radial artery access,” said Fred P. Lampropoulos, Merit Medical’s Chairman and CEO. “By listening to physician feedback, we transformed clinical needs into an advanced compression device that complements our expansive portfolio of solutions designed to support radial artery access procedures and deliver better patient care.”

ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 500 individuals. Merit employs approximately 6,500 people worldwide.

TRADEMARKS Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc. and its subsidiaries in the United States and other jurisdictions.

CONTACTS 

PR/Media Inquiries 
Sarah Comstock 
Merit Medical 
+1-801-432-2864 | sarah.comstock@merit.com

INVESTOR INQUIRIES 
Mike Piccinino, CFA, IRC 
Westwicke – ICR 
+1-443-213-0509 | mike.piccinino@westwicke.com 

  1. Data on File.
  2. Doll JA et al. 2022. “Trends in Arterial Access Site Selection and Bleeding Outcomes Following Coronary Procedures, 2011-2018.” Circ Cardiovasc Qual Outcomes (Mar 11). doi: 10.1161/CIRCOUTCOMES.121.008359. PMID: 35272504.
  3. O’Riordan. 2022. “Radial Access for Angiography and PCI on the Rise in the US.” TCTMD (Mar 16). https://www.tctmd.com/news/radial-access-angiography-and-pci-rise-us

 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.